NCT07123415 2025-11-19
A Phase 1 Study of APX-343A as Monotherapy or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Aptabio Therapeutics, Inc.
Phase 1 Recruiting
Aptabio Therapeutics, Inc.
Trieu, Nguyen Thi, M.D.
Da, Yuwei, M.D.